Meanwhile, ERK1/2, a key component of the MAPK signaling cascade, is frequently upregulated in AML and contributes to uncontrolled proliferation, resistance to apoptosis, and metabolic reprogramming of leukemic cells [61]. The gene discussed is MAPK3; the disease is acute myeloid leukemia.